Compositions and Methods of Making Sustained Release Liquid Formulations
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,318,210 | Compositions and Methods of Making Sustained Release Liquid Formulations In force · High confidence UsedRemaining | Neos Therapeutics, LP | In force | High confidence | ||
| US 9,522,120 | Compositions and Methods of Making Sustained Release Liquid Formulations Term ended Term ended Dec 2, 2025 · High confidence | Neos Therapeutics, LP | Term ended | Term ended Dec 2, 2025 | High confidence | |
| Application 13/685,496 | Compositions and Methods of Making Sustained Release Liquid Formulations Abandoned Abandoned Nov 5, 2013 | Neos Therapeutics, LP | Abandoned | Abandoned Nov 5, 2013 |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Neos Therapeutics, LP.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.